Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 3UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Pancreatic Cancer Liver Metastases 1Neoplasms 1Melanoma 1Locally Advanced Cervical Carcinoma 1Gastric Cancer With Liver Metastases 1Colorectal Neoplasms 1

Interventions

apatinib 4Etoposide 3surufatinib 2Topotecan 2Simvastatin 2Irinotecan 2Drug Therapy 2Carboplatin 2nintedanib 1camrelizumab 1anlotinib 1Tomography, X-Ray Computed 1Sunitinib 1Sorafenib 1Radiotherapy 1Paclitaxel 1PE regimen 1Lithium 1Immunotherapy 1Ifosfamide 1Gemcitabine 1EC regimen 1Cisplatin 1Breathing Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Small Cell Lung Carcinoma × Immunotherapy × Clear all
NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Anhui Provincial Hospital

Phase 1/2 Recruiting
45 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡